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A bstract
The p16/IN K 4A  is one of the m ajor target genes  
in  carcinogenesis and its inactivation  has fre -
quently been reported in  other types of tum ors. 
The purpose of th is study is  to  evaluate in -
activation patterns of p16/INK4A  in  oral squam ous 
cell carcinom a. S ix different oral cancer cell lines, 
SCC-4, SCC-9, SCC-15, SCC-25, KB, and SN U D H - 
379 w ere exam ined for inactivation of p16/IN K 4A  
genes. In the analysis of p16/INK4A gene inactiva -
tion, PC R  am plification , d irect sequencing, and  
m ethylation-specific  PC R  m ethods w ere adopted  
for evaluation of hom ozygous deletion, point m u -
tation, and prom oter hyperm ethylation, respective-
ly . H om ozygous deletion w as detected in  SC C -25  
and SC C -9. SC C -15 show ed hyperm ethylated pro -
m oter region w ithin  p16/IN K4A  gene. It is sugges-
tive in the present study that inactivation patterns  
of p16/IN K 4A  w ere m ainly hom ozygous deletion , 
prom oter m ethylation rather than point m utation in  
oral squam ous cancer cell lines, so treatm ent m o -
dalities o f oral squam ous cell carcinom a should  
be focused on these types of inactivation.
Keywords: homozygous deletion; oral squamous cell 
carcinoma; p16/INK4A; promoter methylation
In troduction
Recent studies have revealed the molecular basis of 
cell cycle control and a critical role of collapsing this 
homeostatic mechanism in carcinogenesis. At the 
core of cell cycle control lies a late G1 checkpoint in 
which critical biochemical activity is achieved by many 
kinds of regulating enzymes. Positioned in late G1 
phase, the regulatory mechanism centered around the 
retinoblastoma tumor suppressor protein (pRb) plays 
an important role by participating in decisions on cell 
cycle progression depending on the cellular environ-
ment (Bartek et al., 1997). Many reports have focused 
on the critical role played by this regulatory mech-
anism known as the pRb pathway (Pardee, 1989; 
Stein et al., 1990; Weinberg, 1995; Hertwig and 
Strauss, 1997; Sellers and Kaelin, 1997; Kim  et al., 
2003).
  The pRb-E2F connection is the heart of the pRb 
pathway in that phosphorylated pRb liberates E2F to 
commence DNA replication and helps cell cycle for-
ward. But phosphorylation of pRb is tightly controlled 
by a variety of regulating enzymes including p16INK4A 
as an inhibitor of phosphorylation. Cell cycle driving 
force exerted by cdk 4 or 6/cyclin D is normally 
balanced with this protein and collapsing this home-
ostatic mechanism is one of the causative factors of 
carcinogenesis (Liggett and Sidransky, 1998). This 
protein is the product of p16/INK4A gene that is one 
of the main target tumor suppressor genes. The 
purpose of this study is to evaluate the role of 
p16/INK4A inactivation in the development of oral 
squamous cell carcinoma by analyzing its inactivation 
pattern of homozygous deletion, point mutation, and 
promoter methylation via PCR amplification, direct 
sequencing, and methylation-specific PCR methods, 
respectively.
M ateria ls and M ethods
C ell lines
Six oral squamous cancer cell lines were used in this 
study including SCC-4, SCC-9, SCC-15, SCC-25, KB, 
and SNUDH-379. HF-3 (human fibroblast cell line), 
Saos-2, and U-2 OS (Osteosarcoma cell lines) were 
used for positive controls. Of these, SCC-4, SCC-9, 
SCC-15, SCC-25, KB, Saos-2, and U-2 OS cell lines 
were obtained from ATCC (American Type Culture 
Collection, Rockville, MD). SNUDH-379 and HF-3 
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were kindly provided by Professor Hong (Seoul Na-
tional University, Seoul, Korea). Tissue sources for 
SCC-4, SCC-9, SCC-15, SCC-25 cell lines were from 
the human tongue (Rheinwald and Beckett, 1981). 
SCC-15 was previously proven to be hypermethylated 
in the p16/INK4A promoter region (Cody et al., 1999; 
Kim et al., 2000), but was included in this experiment 
to be examined for other possible abnormalities in-
cluding homozygous deletion and point mutation. The 
KB cell line, which had been used extensively in 
many studies (Eagle, 1955; Eagle and Foley, 1958; 
Salzman, 1961; Boshart et al., 1984), was also in-
cluded in this study. SNUDH-379 cell line was esta-
blished from pathologically confirmed oral squamous 
cell carcinoma of a less well differentiated type in-
volving maxilla of a 55-year-old female Korean. The 
author included this established cell line in this study 
to test possible alterations of p16/INK4A gene.
  SCC-4, SCC-9, SCC-15, and SCC-25 cell lines 
were cultured in Ham's F12/DMEM (1:1) supple-
mented with 10% FBS, and 0.4 µg/ml hydrocortisone. 
KB and SNUDH-379 cell lines were cultured in DMEM 
supplemented with 10% FBS. Initial passages were 
performed when heavy tumor cell growth was ob-
served and subsequent passages were performed 
every four or five day on all of these six cell lines. 
Twenty to twenty five passages were performed on 
SCC-4, SCC-9, SCC-15, SCC-25, and KB cell lines 
and between 15 and 20 on SNUDH-379. All cultured 
cells were in the late log phase growth at 75-80% 
confluence immediately before DNA isolation. Names, 
origins, sources, and culture media of the cell lines 
that were used are listed in Table 1.
D N A  isolation
Cell monolayers were washed in PBS and lysed in 
2 ml of DNA lysis buffer (50 mL of STE (0.1 M NaCl, 
10 mM Tris, pH 8.0) buffer, 1 ml of 0.5 M EDTA, 
5 ml of 10% sodium dodecyl sulfate) and 100 µl of 
20 mg/ml proteinase K was added to the samples. 
After the samples were incubated at 60oC for 2 h, 
DNA was isolated from the samples with phenol and 
chloroform, precipitated with ethanol, and re-dissolved 
in 50 µl of water.
D eterm ination  of deletion and point m utation
Polymerase chain reaction (PCR) amplification
Samples were examined for deletion of exon 1 and 
exon 2 of p16/INK4A gene by the PCR amplification 
method. Exon 1 was amplified as one fragment while 
exon 2 was split into two fragments. HF-3 cell line 
was used as an internal positive control for the 
p16/INK4A amplification. The primers used for PCR 
amplification were designed from the published 
p16/INK4A sequences (Zhang et al., 1994) and are 
listed in Table 2.
  Two hundred ng of purified DNA were amplified in 
a 20 µl solution containing 1×PCR buffer, 1.5 mM 
MgCl2, 1 µM of each primer, 0.125 mM of each de-
oxynucleotide triphosphate, 5% dimethylsulphoxide 
(DMSO), and 1 U of Taq polymerase. Thirty-five cy-
cles of PCR were completed using GeneAmp PCR 
system 2400 (PE applied biosystem, Foster City, CA) 
under the following conditions: denaturation at 95oC, 
60 s; annealing at 60oC, 60 s; and extension at 72oC, 
60 s. Amplified PCR products were electrophoresed 
on 1.8% agarose gels. The absence of visible bands 
amplified by PCR indicated homozygous deletion.
D irect sequencing
PCR products were directly sequenced by a PCR- 
based sequencing method using the BigDye termina-
tor cycle sequencing kit (PE applied biosystem, Foster 
City, CA) with Genetic Analyzer 310 (PE applied 
biosystem, Foster City, CA). Briefly, following the 
cleanup of PCR product using PCR purification kit 
(Qiagen, Valencia, CA) the 200 ng of purified PCR 
products and 4 pM of primers were mixed with 
T a b le  1 . Cell lines used.
ꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚ
Name Origin Source Culture Media
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
SCC-4 Tongue squamous cell carcinoma ATCCa DMEM/F12(1:1), 10% FBS
SCC-9 Tongue squamous cell carcinoma ATCC DMEM/F12(1:1), 10% FBS
SCC-15 Tongue squamous cell carcinoma ATCC DMEM/F12(1:1), 10% FBS
SCC-25 Tongue squamous cell carcinoma ATCC DMEM/F12(1:1), 10% FBS
KB Mouth squamous cell carcinoma ATCC DMEM, 10% FBS
SNUDH-379 Gingiva squamous cell carcinoma SNUDHb DMEM, 10% FBS
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
a, American Type Culture Collection, Rockville, MD, USA; b, Seoul National University Dental Hospital, Seoul, Korea
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BigDye reaction mixture to make a total volume of 
20 µl. Twenty-five cycles of PCR reactions were done 
under the following conditions: denaturation at 96oC 
for 10 s; annealing at 50oC for 5 s; and extension 
at 60oC for 4 min. Reaction products were loaded into 
the Genetic Analyzer 310 (PE applied biosystem, 
Foster city, CA) for electrophoresis.
D eterm ination of prom oter m ethylation
Three types of methylation-specific PCRs were de-
signed; methylation-specific PCRs with unmodified 
DNA samples and wild-type primer pairs, those with 
modified DNA samples and unmethylation-specific pri-
mer pairs, and those with modified DNA samples and 
methylation-specific primer pairs, respectively. Three 
primer pairs were used as wild-type, unmethylation- 
specific, and methylation-specific PCR primers, re-
spectively. These primer pairs were designed after the 
published sequences (Herman et al., 1996) and are 
listed in Table 2. Saos-2 and U-2 OS cell lines were 
used as positive control for unmethylation-specific, 
methylation-specific PCR, respectively. Reported me-
thylation status of these two controls (Otterson et al., 
1995) was used to determine the internal positive 
controls. Sample DNAs were modified for unmethyl-
ation-specific and methylation specific PCRs. One µg 
of DNA in a volume of 50 µl was denatured by 0.2 
M of NaOH for 10 min at 37oC. Thirty µl of 10 mM 
hydroquinone (Sigma, St. Louis, MO) and 520 µl of 
3 M sodium bisulfite (Sigma, St. Louis, MO) of pH 
5, both freshly prepared, were added and mixed, and 
the samples were incubated under mineral oil at 50oC 
for 16 h. Modified DNA was purified using the Qiagen 
DNA purification kit (Qiagen, Valencia, CA) according 
to the manufacturer and eluted into 50 µl of water. 
Modification was completed via treatment by 0.3 M 
of NaOH for 5 min at room temperature, followed by 
ethanol precipitation. DNA was resuspended in water 
and used immediately or stored at -20oC for later use.
  The PCR mixture contained 1×PCR buffer, 1.5 
mM MgCl2, 1 µM of each primer, 0.125 mM of each 
deoxynucleotide triphosphate, 5% dimethylsulphoxide 
(DMSO), 1 U of Taq polymerase, and 100 ng of 
unmodified or bisulfite-modified DNAs in a final vol-
ume of 50 µl. Reactions were hot-started at 95oC for 
5 min before the addition of 1 U of Taq polymerase. 
Amplification was carried out for 35 cycles under the 
following conditions. Unmodified DNA was denatured 
for 30 s at 95oC, annealed for 30 s at 60oC, and 
extended for 30 s at 72oC with wild-type primer pairs. 
The condition for unmethylation-specific PCR was the 
same except that the annealing temperature was 
56oC with unmethylation-specific primer pairs. Meth-
ylation-specific PCR was done under the same con-
ditions as the unmethylation-specific PCR except that 
the annealing temperature was 58oC with meth-
ylation-specific primer pairs. Final extension was done 
T a b le  2 . O ligonucleotide primers used for polymerase chain reactions (PCR) and methylation-specific PCR (MSP).
ꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚ
Primer set Sequence Size(bp)
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
Sense 5'TCTGCGGAGAGGGGGAGAGCAGGCA3'
p16E1a       ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ    279
Antisense 5'GCGCTACCTGATTCCAATTC3'
           ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
PCR Sense 5'ACAAGCTTCCTTTCCGTCATGCCG3'
p16E2a       ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ    244
Antisense 5'CCAGGCATCGCGCACGTCCA3'
           ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
Sense 5'TTCCTGGACACGCTGGTGGT3'




p16W b        ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ    140
Antisense 5'CGGGCCGCGGCCGTGG3'
           ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
MSP Sense 5'TTATTAGAGGGTGGGGTGGATTGT3'
p16U         ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ    151
Antisense 5'CAACCCCAAACCACAACCATAA3'
           ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
Sense 5'TTATTAGAGGGTGGGGCGGATCGC3'
p16M          ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ    150
Antisense 5'GACCCCGAACCGCGACCGTAA3'
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
aE1: Exon 1, bW: wild-type primers, E2a: 5' fragment of Exon 2, U: unmethylation-specific primers, E2b: 3' fragment of Exon 2, M: methylation-
specific primers.
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for 5 min at 72oC in all three types of methyla-
tion-specific PCRs. Controls without DNA were per-
formed for each set of PCRs. Each PCR product was 
directly loaded on 1.8% agarose gels, and directly 
visualized under UV illumination.
R esu lts
H om ozygous deletion rather than point m utation  
on the p16/IN K 4A  loci
Six tumor DNA samples were subjected to PCR for 
the assessment of homozygous deletion. Exon 1 and 
exon 2 of p16/INK4A were independently amplified 
using HF-3 primers in the same reactions as an 
internal positive control. Because of the large size of 
exon 2 (307 bp), it was amplified as two separate 
fragments. Homozygous deletions of the p16/INK4A 
gene were detected in two of six oral cancer cell 
lines. Exon 1 and exon 2 of the p16/INK4A gene 
were entirely deleted homozygously in SCC-25, and 
only exon 1 was deleted in SCC-9 (Figure 1). On the 
other hand, no alterations were detected in SCC-4, 
SCC-15, KB, and SNUDH-379. We have directly se-
F ig u re  1 . Analysis of p16/INK4A  exon 1 (A), exon 2a (B), and exon
2b (C) by PCR. Each exon was amplified by PCR and 20 µ l of PCR
products were separated on a 1.8%  agarose gel. The bands 
corresponding to the predicted molecular weights of p16/INK4A 
amplicons are indicated by arrows: A, 279 bp for exon 1; B, 244 bp
for exon 2a; and C, 242 bp for exon 2b. Results showed the bands
were lost at exon 1 in SCC-9 and SCC-25 (lane 5 and 7, respectively
in A) and lost at exon 2 in SCC-25 (lane 7 in B and C). 1) DNA
size marker; pUC 18 Msp I digest, 2) Absence of DNA (negative 
control), 3) HF-3 (positive control), 4) SCC-4, 5) SCC-9, 6) SCC-15, 













F ig u re  2 . Analysis of methylation status of p16/INK4A promoter 
regions by methylation-specific PCR. (A) Methylation-specific PCR 
product of unmodified DNA with wild-type primer pairs. All of the 
experimental cell lines showed visible bands at predicted molecular
weights (140 bp) except the SCC-9 and SCC-25 (lane 6 and 8, 
respectively) which in previous experiment were proven to have 
deletions of p16/INK4A  genes (Figure 1A). (B) Methylation-specific 
PCR product of modified DNA with unmethylation-specific primer pairs.
The bands were seen at predicted molecular weights (151 bp) in 
SCC-4, KB, SNUDH-379 (lane 5, 9, 10, respectively). (C) Methylation-
specific PCR product of modified DNA with methylation-specific primer
pairs. The band was seen at predicted molecular weights (150 bp)
only in SCC-15 (lane 7). 1) DNA size marker; pUC 18 Msp I digest,
2) Absence of DNA (negative control), 3) Saos-2 (positive control for
unmethylation-specific PCR), 4) U-2 OS (positive control for methyl-
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quenced all six tumor DNA samples for detection of 
point mutations but none of them showed any point 
mutations.
M ethylation status in  the prom oter region  of the  
p16/IN K 4A  gene
Primer sequences were chosen for regions containing 
frequent cytosines to distinguish wild-type from mod-
ified DNA. Besides, CpG pairs near the 3' end of the 
primers were selected in determining the primer se-
quences to provide maximal discrimination in the PCR 
between unmethylated and methylated DNA. All the 
samples were subjected to methylation-specific PCR 
for the detection of methylation in the promoter region 
of the p16/INK4A gene. In PCR using wild-type primer 
pairs with unmodified samples, PCR products were 
detected in SCC-4, SCC-15, KB, and SNUDH-379 but 
not in SCC-9 and SCC-25 (Figure 2A). In PCR using 
unmethylation-specific primer pairs with bisulfite-mod-
ified samples, PCR products were detected in SCC-4, 
KB, and SNUDH-379 but not in SCC-9, SCC-15 and 
SCC-25 (Figure 2B). In PCR using methylation- 
specific primer pairs with bisulfite-modified samples, 
only SCC-15 yielded PCR product (Figure 2C). The 
results of methylation-specific PCRs are summarized 
in Table 3. 
D iscussion
In the amplification study for exon 1, no bands were 
found in SCC-9 and SCC-25 as shown at lane 5 and 
7, respectively in Figure 1A. In the case with exon 
2, the band was lost in SCC-25 only at lane 7 in 
Figure 1B and C. From the fact that p16/INK4A was 
deleted only at exon 1 in SCC-9 and deleted at both 
exon 1 and 2 in SCC-25, we have concluded that 
each of the exons is independently deleted and any 
deletion of these exons can lead to inactivation of 
p16/INK4A gene. In this study, the author adopted 
PCR amplification method, not RT-PCR method, for 
assessment of the deletion because the reaction 
product would be complementary DNA and not gen-
omic DNA in RT-PCR. p16/INK4A gene is made up 
of three exons, which were spliced by two introns: 
a 5' region of 126 bp (exon 1), a middle region of 
307 bp (exon 2), and 3' region of 11 bp (exon 3). 
In the deletion analysis, we only included exon 1 and 
exon 2 because the 3' region (exon 3) contains only 
11 bp of genes and this was considered negligible.
  In many types of malignant tumors, homozygous 
deletion of p16/INK4A gene and hypermethylation of 
the promoter CpG island are main causes of tumori-
genesis (Mead et al., 1994; Brenner et al., 1996; 
Marchini et al., 1997; Drexler, 1998; Tsutsumi et al., 
1998; Wei et al., 1999). In primary tumors, the rate 
of p16/INK4A point mutation approximates 10% or so 
(Sartor et al., 1999; Wu et al., 1999). In an experi-
mental study using eight oral squamous cancer cell 
lines, point mutation was found in five of six cell lines 
as the causative factor for p16/INK4A gene inacti-
vation (Sartor et al., 1999). In the present study, 
authors could not find any point mutations in direct 
sequencing procedures of all six cell lines. This 
difference was partially due to the difference in cell 
lines. There was not a single matched cell line in 
these two studies. In addition to the complete mis-
match of the cell lines, the cause of this difference 
may partly have been the sample size. The sample 
numbers of both studies were inadequate for statis-
tical evaluation. It is discreetly considered that for a 
comparative study using data, the sample size should 
be increased.
  There have been some differences in the past 
between the alteration rate of p16/INK4A gene and 
the expression rate of its gene product. Expression 
loss of p16INK4A protein has approached to 70% in 
non-small cell lung carcinomas (Otterson et al., 1994). 
But the rate of p16/INK4A gene alteration in the same 
diagnosis was much lower in other experiments 
(Bonetta, 1994; Mead et al., 1994). Some mechanism 
other than point mutation and deletion of genes was 
speculated and it is now known that hypermethylation 
of the promoter region causes transcriptional silencing 
and thus blocks translational procedures. In normal 
conditions, cytosines in CpG-poor region are meth-
ylated in contrast to the cytosines in the CpG islands, 
T a b le  3 . Results of Methylation-specific PCR.
ꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚꠚ
Primer set SCC-4 SCC-9 SCC-15 SCC-25 KB SNUDH-379
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
 p16-W a + - + - + +
 p16-Ub + - - - + +
 p16-Mc - - + - - -
ꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏꠏ
a, W : unmodified or wild-type primers; b, U: unmethylation-specific primers; c, M : methylation-specific primers.
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which are hardly methylated. This normal type of 
reading frame is recognized by the unmodified pri-
mers, which are wild-type primers. All forms of cyto-
sines, dispersed in CpG-poor region or clustered as 
in CpG island, will be replaced by uracil when it is 
treated by bisulfite if they are unmethylated. But if 
methylated, cytosines remain the same in spite of its 
treatment by bisulfite. In this experiment, three primer 
pairs were used as unmodified, unmethylation-speci-
fic, and methylation-specific primers. Unmethylation- 
specific and methylation-specific primer pairs detected 
these uracils and 5-methylcytosines in reading frames, 
respectively. Methylation-specific PCR is sensitive and 
specific for methylation of virtually any block of CpG 
sites in CpG islands requiring only a small sample 
and being able to rule out pseudopositive reaction 
caused by partial digestion of methylation-sensitive 
enzymes used in other methylation studies (Herman 
et al., 1996). In methylation-specific PCR with wild- 
type primer pairs, the bands were intact except in 
SCC-9 and SCC-25 (lane 6 and lane 8, respectively 
in Figure 2A) meaning that the promoter regions of 
the cell lines were intact except in SCC-9 and SCC- 
25 regardless of the methylation status. In methyla-
tion-specific PCR with unmethylation-specific primer 
pairs, the bands were lost in SCC-9, SCC-15, and 
SCC-25 (lane 6, 7, and 8 in Figure 2B). Considering 
the deletion of p16/INK4A gene was previously iden-
tified in SCC-9 and SCC-25, the only abnormality 
found in this result was SCC-15 and this was con-
firmed by further experiments with methylation-specific 
primer pairs. As was expected, the result was positive 
only in SCC-15 in methylation-specific PCR with 
methylation-specific primer pairs (lane 7 in Figure 2C). 
The result shows that CpG islands in promoter region 
of p16/INK4A gene are hypermethylated only in 
SCC-15 of six oral squamous cancer cell lines sel-
ected. Promoter hypermethylation plays a role in the 
inactivation of p16/INK4A gene in oral squamous cell 
carcinomas. 
  Authors analyzed inactivation patterns of p16/INK4A 
genes to evaluate the role of p16/INK4A inactivation 
in the development of oral squamous cell carcinoma. 
Three kinds of inactivation patterns were examined; 
homozygous deletion by PCR amplification, point mu-
tation by direct sequencing, and promoter methylation 
by methylation-specific PCR methods, respectively. 
p16/INK4A gene was deleted at exon 1 and exon 2 
in SCC-25, and partially deleted at exon 1 in SCC-9. 
Promoter region of p16/INK4A gene was hypermeth-
ylated in SCC-15. But we could not find any evidence 
of point mutations in all the six cell lines. In this study, 
inactivation patterns of p16/INK4A were mainly homo-
zygous deletion, promoter methylation rather than 
point mutation in oral squamous cancer cell lines, and 
it is suggested that treatment modalities of oral squa-
mous cell carcinoma should be focused on these 
types of inactivation.
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